What this site is
A plain-language synthesis of the peer-reviewed literature on high-reactive temperament and behavioral inhibition – chiefly Jerome Kagan’s Harvard longitudinal research and the studies built around it. The aim is to be genuinely useful to parents, teens, and adults without overstating what the science can actually tell an individual.
Who writes this
High Reactive is written and maintained by an independent editorial team, not by a single named clinician – and we won’t pretend otherwise. Each page is compiled directly from the primary research and review literature, every substantive claim is tied to a named study in a “Selected sources” list, and pages carry a “last reviewed” date so you can see how current they are. We re-read the sources and revise when the evidence moves.
What that means for you: treat this as a well-referenced starting point written by careful generalists, not as the opinion of your child’s doctor. For an individual situation, a qualified clinician who can actually assess the person is the right authority – this site is here to help you ask better questions when you get there. Found something wrong or out of date? hello@highreactive.com.
How we read the evidence
A few principles guide every page here:
- Predisposition, not destiny. Temperament tilts the odds; it does not decide the outcome. We avoid language that turns a population statistic into a personal prophecy.
- Weight by evidence quality. Kagan’s longitudinal and neuroimaging line carries the most weight. The Highly Sensitive Person framework is treated as a useful, partly overlapping construct with a thinner, mostly self-report base – not its equal in rigor.
- Flag the uncertainty. Where findings are modest, contested, or hard to replicate, we say so rather than rounding up.
- No diagnosis, no selling. Nothing here is medical advice, and there is nothing to buy.
The caveats we want you to keep
- Individual prediction is modest. Most high-reactive infants never develop clinical anxiety, and some children with no early markers do. Group findings are not forecasts for one person.
- Sample limits. Kagan’s original cohorts were largely middle-class and Caucasian, from the Boston area. Reactivity distributions replicate across cultures, but the social meaning of inhibition varies.
- Category vs. dimension. The evidence now favors a continuum with extreme tails over a clean “type” of child.
- HSP / SPS has a thinner base. Many findings rest on a single self-report scale and overlap with neuroticism and introversion.
- Genetics are probabilistic. 5-HTTLPR effects are real but small and heterogeneous; no single gene causes high reactivity.
- Treatment has limits. CBT is first-line for social anxiety, but the overall remission rate across studies is about 51% – effective, not a guaranteed cure.
- Popularizations overreach. Conflating high reactivity with introversion, or claiming a sharp orchid/dandelion split, goes beyond what the data support.
Get in touch
Spotted an error, a study we should cite, or a place where we’ve overstated the case? We’d genuinely like to know – write to hello@highreactive.com.
This site is educational information, not a diagnosis or a treatment plan. If a temperament is tipping into something that limits a life, a qualified clinician is the right next step. In the U.S., call or text 988 any time for crisis support.